Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation

[1]  Jun Zhao,et al.  microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  X. Yang,et al.  miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2. , 2017, American journal of cancer research.

[3]  Dahong Zhang,et al.  miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[5]  Ting Li,et al.  MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer , 2016, Tumor Biology.

[6]  I. Ng,et al.  Up‐regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis , 2016, Hepatology.

[7]  Jidong Zhu,et al.  Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53 , 2015, Nature Communications.

[8]  L. Pfeffer,et al.  MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity , 2015, Oncogene.

[9]  G. Stein,et al.  Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease. , 2015, Cancer research.

[10]  Jer-Yen Yang,et al.  Molecular and Cellular Pathobiology H 3 K 9 Histone Methyltransferase , KMT 1 E / SETDB 1 , Cooperates with the SMAD 2 / 3 Pathway to Suppress Lung Cancer Metastasis , 2014 .

[11]  Jing Wang,et al.  MiR‐7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway , 2014, Stem cells.

[12]  A. Papavassiliou,et al.  High‐frequency p16INK4A promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma , 2014, Experimental dermatology.

[13]  A. Papavassiliou,et al.  Role of Histone Lysine Methyltransferases SUV39H1 and SETDB1 in Gliomagenesis: Modulation of Cell Proliferation, Migration, and Colony Formation , 2014, NeuroMolecular Medicine.

[14]  J. Hou,et al.  Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion , 2014, Asian journal of andrology.

[15]  M. Esteller,et al.  Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis , 2013, Oncogene.

[16]  T. Sellers,et al.  Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer , 2013, Oncogene.

[17]  D. Hwang,et al.  Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. , 2012, The Journal of clinical investigation.

[18]  A. Yoshimura,et al.  MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells , 2012, International journal of oncology.

[19]  R. Agami,et al.  MicroRNA regulation by RNA-binding proteins and its implications for cancer , 2011, Nature Reviews Cancer.

[20]  S. Minucci,et al.  SILAC-based proteomic analysis to dissect the “histone modification signature” of human breast cancer cells , 2011, Amino Acids.

[21]  Steven J. M. Jones,et al.  DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. , 2011, Cell stem cell.

[22]  David A. Orlando,et al.  The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset , 2011, Nature.

[23]  Peter T Nelson,et al.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. , 2010, Journal of molecular biology.

[24]  H. Kimura,et al.  Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET , 2010, Nature.

[25]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[26]  J. Issa,et al.  Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells , 2008, PloS one.

[27]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[28]  J. Lieberman,et al.  let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.

[29]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[30]  Anwar Hossain,et al.  Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.

[31]  A. Riggs,et al.  The Histone Methyltransferase SETDB1 and the DNA Methyltransferase DNMT3A Interact Directly and Localize to Promoters Silenced in Cancer Cells* , 2006, Journal of Biological Chemistry.

[32]  T. Tuschl,et al.  Identification of Novel Argonaute-Associated Proteins , 2005, Current Biology.

[33]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[34]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[35]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[36]  Shireen A. Sarraf,et al.  Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. , 2004, Molecular cell.

[37]  M. Rederstorff,et al.  Dual luciferase gene reporter assays to study miRNA function. , 2015, Methods in molecular biology.

[38]  A. Jemal,et al.  Breast cancer statistics, 2013 , 2014, CA: a cancer journal for clinicians.

[39]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .